Riskpilot← Back to searchSign inGet full accessDERMATECH AS
ASActiveOrg 931783505Skolegata 14, 2010 StrømmenWholesale of perfume and cosmetics · NACE 4645Est. 20230 employees
Revenue 2024
NOK 641K
EBITDA margin
19.9%
+2239% vs 2023
Equity ratio
8.7%
Financial strength
Net profit 2024
NOK 60K
+1106% vs 2023
| Revenue | NOK 641K | — |
| EBITDA | NOK 128K | +2239% |
| Net profit | NOK 60K | +1106% |
| Total assets | NOK 1,3M | +2331% |
| Equity | NOK 114K | +111% |
| Employees | 0 | — |
Legal name
DERMATECH AS
Org number
931783505
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
27. juli 2023
Share capital
NOK 60 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder eller nestleder hver for seg. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Handel/engros salg av produkter til hud og kroppspleie bygget på innovative ingredienser med høy renhet basert på forskning og hva som står i forbindelse med dette. Selskapet vil kunne inneha produktrettigheter, i tillegg til rettighetsbeskytte de varemerker og produkter som selskapet utvikler. Import og eksport av legemidler. Import og salg av elektromedisinsk utstyr og maskiner til medisinske klinikker og mot skjønnhetsbransjen, samt konsulenttjenester. Selskapet kan ved innskudd eller på annen måte interessere seg i andre foretagender, enten direkte eller ved aksjetegning i næringsdrivende selskaper.
Address
Skolegata 14, 2010 Strømmen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 641 |
| Staff expenses | −0 | −0 |
| EBITDA | −6 | 128 |
| Depreciation & amort. | −0 | −51 |
| EBIT | −6 | 77 |
| Net financials | 0 | −0 |
| Profit before tax | −6 | 76 |
| Tax | −0 | 16 |
| Net profit | −6 | 60 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 54 | 1 314 |
| Equity | 54 | 114 |
| Long-term debt | 0 | 9 |
| Short-term debt | 0 | 1 191 |
| Total debt | 0 | 1 199 |
EBITDA margin
19.9%
This company
15.8%
Market median
+26% vs market
20232024
Equity ratio
8.7%
This company
38.2%
Market median
-77% vs market
20232024
Return on equity
52.7%
This company
18.4%
Market median
+186% vs market
20232024
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20232024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20232024
Debt / equity
10.51×
This company
0.62×
Market median
-1595% vs market
20232024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-07-04 – 2023-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2023 | — | — | |
| Chairman | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DERMATECH AS 
REGENESIS INTERNATIONAL ASBoard members of DERMATECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Wai Man Chan | Deputy Chairman | 0 companies |
| Kingsley Mariadasan | Chairman | 0 companies |